Targeting Tumor Metabolic Adaptations in the Metastatic Niche to Improve Therapy Efficacy

In this webinar, we discuss how the IN SITE™ Metastasis Kit can enable researchers to model common metastatic microenvironments. Dr. Evelyn Aranda and Dr. Zeynep Madak-Erdogan discuss how to evaluate anti-cancer therapeutics in physiologically-relevant tumor models, to investigate metabolic changes in hormone-positive breast cancer, and to identify mechanisms of tumor drug resistance.